Osteochondral alterations in osteoarthritis

被引:248
作者
Suri, Sunita [1 ]
Walsh, David A. [1 ]
机构
[1] Univ Nottingham, Arthrit Res UK Pain Ctr, City Hosp Nottingham, Nottingham NG5 1PB, England
关键词
Osteochondral junction; Bone; Cartilage; Osteoarthritis; Vessels; Pain; SUBCHONDRAL VASCULAR SYSTEM; ENDOTHELIAL GROWTH-FACTOR; KNEE OSTEOARTHRITIS; CARTILAGE DEGRADATION; RAT MODEL; METALLOPROTEINASE INHIBITOR; ENDOCHONDRAL OSSIFICATION; CHONDROCYTE PHENOTYPE; STRUCTURAL ARTHRITIS; BIOCHEMICAL MARKERS;
D O I
10.1016/j.bone.2011.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoarthritis (OA) is a major cause of pain and disability in the aging population, but its pathogenesis remains incompletely understood. Alterations beneath the articular cartilage at the osteochondral junction are attracting interest as possible mediators of pain and structural progression in OA. Osteochondral changes occur early during the development of OA and may aggravate pathology elsewhere in the joint. Loss of osteochondral integrity removes the barrier between intra-articular and subchondral compartments, exposing subchondral bone and its nerves to abnormal chemical and biomechanical influence. Osteochondral plasticity results in a merging of tissue compartments across the junction. Loss of the clearly differentiated demarcation between bone and articular cartilage is associated with invasion of articular cartilage by blood vessels and sensory nerves, and advancing endochondral ossification. Increased subchondral bone turnover is intimately associated with these alterations at the osteochondral junction. Cells signal across the osteochondral junction, and this cross-talk may be both a consequence of, and contribute to these pathological changes. Bone turnover, angiogenesis and nerve growth are also features of other diseases such as osteoporosis and cancers, for which therapeutic interventions are already advanced in their development. Here we review pathological changes at the osteochondral junction and explore their potential therapeutic implications for OA. This article is part of a Special Issue entitled "Osteoarthritis". (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:204 / 211
页数:8
相关论文
共 81 条
[1]   Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors [J].
Abdiche, Yasmina Noubia ;
Malashock, Dan Stephen ;
Pons, Jaume .
PROTEIN SCIENCE, 2008, 17 (08) :1326-1335
[2]   Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis [J].
Agnello, KA ;
Trumble, TN ;
Chambers, JN ;
Seewald, W ;
Budsberg, SC .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2005, 66 (09) :1487-1495
[3]   Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis [J].
Aigner, Thomas ;
Fundel, Katrin ;
Saas, Joachim ;
Gebhard, Pia M. ;
Haag, Jochen ;
Weiss, Tilo ;
Zien, Alexander ;
Obermayr, Franz ;
Zimmer, Ralf ;
Bartnik, Eckart .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3533-3544
[4]   Transforming growth factor a suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis [J].
Appleton, C. Thomas G. ;
Usmani, Shirine E. ;
Bernier, Suzanne M. ;
Aigner, Thomas ;
Beier, Frank .
ARTHRITIS AND RHEUMATISM, 2007, 56 (11) :3693-3705
[5]   Rho/ROCK and MEK/ERK activation by transforming growth factor-α induces articular cartilage degradation [J].
Appleton, C. Thomas G. ;
Usmani, Shirine E. ;
Mort, John S. ;
Beier, Frank .
LABORATORY INVESTIGATION, 2010, 90 (01) :20-30
[6]  
Ashraf S, 2011, ARTHRITIS RHEUM
[7]   Angiogenesis and the Persistence of Inflammation in a Rat Model of Proliferative Synovitis [J].
Ashraf, Sadaf ;
Mapp, Paul I. ;
Walsh, David A. .
ARTHRITIS AND RHEUMATISM, 2010, 62 (07) :1890-1898
[8]   Role of the subchondral vascular system in endochondral ossification:: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro [J].
Babarina, AV ;
Möllers, U ;
Bittner, K ;
Vischer, P ;
Bruckner, P .
MATRIX BIOLOGY, 2001, 20 (03) :205-213
[9]   A New Class of Potent Matrix Metalloproteinase 13 Inhibitors for Potential Treatment of Osteoarthritis Evidence of Histologic and Clinical Efficacy Without Musculoskeletal Toxicity in Rat Models [J].
Baragi, Vijaykumar M. ;
Becher, Gabriel ;
Bendele, Alison M. ;
Biesinger, Ralf ;
Bluhm, Harald ;
Boer, Juergen ;
Deng, Hongbo ;
Dodd, Rory ;
Essers, Michael ;
Feuerstein, Tim ;
Gallagher, Brian M., Jr. ;
Gege, Christian ;
Hochguertel, Matthias ;
Hofmann, Michael ;
Jaworski, Andreas ;
Jin, Lixia ;
Kiely, Andrew ;
Korniski, Brian ;
Kroth, Heiko ;
Nix, Darrell ;
Nolte, Bert ;
Piecha, Dorothea ;
Powers, Timothy S. ;
Richter, Frank ;
Schneider, Matthias ;
Steeneck, Christoph ;
Sucholeiki, Irving ;
Taveras, Arthur ;
Timmermann, Andreas ;
Van Veldhuizen, Joshua ;
Weik, Juergen ;
Wu, Xinyuan ;
Xia, Bing .
ARTHRITIS AND RHEUMATISM, 2009, 60 (07) :2008-2018
[10]   SUBCHONDRAL PATHWAYS TO THE SUPERIOR SURFACE OF THE HUMAN TALUS [J].
BERRY, JL ;
THAELEROBERDOERSTER, DA ;
GREENWALD, S .
FOOT & ANKLE, 1986, 7 (01) :2-9